Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Gene expression changes between control and TSC patient neurons

From: Pharmacological intervention to restore connectivity deficits of neuronal networks derived from ASD patient iPSC with a TSC2 mutation

Target gene

RNA abundance (mean ± SEM)

Change

Control neurons

TSC neurons

GABAergic cells

DLX1

0.016 ± 0.009

0.002 ± 0.0004

 

DLX2

0.03 ± 0.01

0.05 ± 0.01

 

LHX6

0.08 ± 0.02

0.11 ± 0.02

 

VGAT

0.03 ± 0.01

0.04 ± 0.01

 

Synaptic

PSD95

0.21 ± 0.05

0.12 ± 0.02

 

Synaptophysin

0.07 ± 0.01

0.11 ± 0.03

 

Homer1

0.37 ± 0.07

0.43 ± 0.05

 

GABA/glutamate signalling

GAD65

0.034 ± 0.02

0.17 ± 0.07*

GAD67

0.13 ± 0.07

1.74 ± 0.61**

GABAα1

0.33 ± 0.05

0.50 ± 0.02

 

GABAα2

0.31 ± 0.06

1.14 ± 0.07***

GABAβ1

0.72 ± 0.09

1.59 ± 0.43*

GABAγ1

0.062 ± 0.006

0.26 ± 0.03***

Grin2a

0.27 ± 0.08

0.14 ± 0.007

 

Grin2b

1.35 ± 0.26

0.82 ± 0.06

 

Grin3A

0.13 ± 0.036

0.29 ± 0.05*

GRIN1

0.07 ± 0.007

0.18 ± 0.04**

GRIA1

1.03 ± 0.14

3.51 ± 1.04*

Vglut1

0.06 ± 0.009

0.004 ± 0.002**

Vglut2

0.1 ± 0.04

3.11 ± 0.85**

  1. *p <  0.05; **p < 0.01; ***p < 0.001 (unpaired t test)